Use of adjunctive periodontal therapy for type 2 diabetics with gum disease

Summaries 1 min 305

Font Size

Created On: 31/08/2024

To study how diverse local treatments used alongside non-surgical periodontal therapy (NSPT) can reduce pocket depth (PD), increase clinical attachment level (CAL), and lower glycated haemoglobin (HbA1c) levels in individuals with both type 2 diabetes mellitus (T2DM) and periodontitis.

See All

Key take away

Using Metformin or statins may help treat patients with type 2 diabetes and periodontitis non-surgically, presenting a strategic approach to manage both systemic and oral health challenges simultaneously.

Background

Method

Thirty-two studies met the inclusion criteria. The quality assessment indicated that 58.04% of the studies had a low risk of bias (ROB), 22.32% had an unclear ROB, and 19.64% had a high ROB. Two trials were excluded from the meta-analysis due to incomplete data and non-responsiveness.

Result

This network meta-analysis of 30 RCTs with 1224 patients showed that short (i.e. 2 to 3 months) and medium-term (i.e. 4 to 6 months) therapies favored statins or Metformin over scaling and root planing (SRP) alone or with adjunctive therapies. Statins, followed by antibiotics showed the most noteworthy decreases in PD and gains in CAL in the long term (>6 months). Photodynamic and laser therapies were more effective in short-term HbA1c reduction than SRP with or without statins, antiseptics, or placebo.

Conclusion

This study provides moderate evidence suggesting that adding Metformin or statins to NSPT could potentially enhance reductions in PD and improvements in CAL, compared to treatments involving SRP with or without a placebo.

Source:

Journal of Dentistry

Link:

https://pubmed.ncbi.nlm.nih.gov/38936456/

Article:

Efficacy of adjunctive local periodontal treatment for type 2 diabetes mellitus patients with periodontitis: a systematic review and network meta-analysis